Harvard Apparatus Regenerative Tech Files 2024 10-K
Ticker: HRGN · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1563665
| Field | Detail |
|---|---|
| Company | Harvard Apparatus Regenerative Technology, Inc. (HRGN) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, cybersecurity
TL;DR
HRGN 10-K filed: $60M shares authorized, CFO handles cyber risk. FY24 financials out.
AI Summary
Harvard Apparatus Regenerative Technology, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Biostage, Inc., is based in Holliston, MA. Their Chief Financial Officer is responsible for assessing and managing cybersecurity risks. The filing indicates a total of $60,000,000 in authorized shares.
Why It Matters
This filing provides a comprehensive overview of Harvard Apparatus Regenerative Technology's financial health and operational status for the past fiscal year, offering insights for investors and stakeholders.
Risk Assessment
Risk Level: low — The provided snippet is a standard 10-K filing header and does not contain specific risk factors or financial distress indicators.
Key Numbers
- $60,000,000 — Authorized Shares (Total number of shares the company is authorized to issue.)
- 2024-12-31 — Fiscal Year End (The end date of the reporting period.)
- 2025-03-31 — Filing Date (The date the 10-K was filed with the SEC.)
Key Players & Entities
- Harvard Apparatus Regenerative Technology, Inc. (company) — Filer
- Biostage, Inc. (company) — Former company name
- Holliston, MA (location) — Business and mail address
- December 31, 2024 (date) — Fiscal year end
- $60,000,000 (dollar_amount) — Authorized shares
FAQ
What was Harvard Apparatus Regenerative Technology's revenue for the fiscal year ending December 31, 2024?
The provided snippet does not contain specific revenue figures for the fiscal year ending December 31, 2024.
Who is responsible for managing cybersecurity risks at Harvard Apparatus Regenerative Technology?
The Chief Financial Officer is primarily responsible for assessing and managing material risks from cybersecurity threats.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code for Harvard Apparatus Regenerative Technology, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
When did the company change its name from Biostage, Inc.?
The company changed its name from Biostage, Inc. on March 31, 2016.
What is the company's business address?
The business address is 84 October Hill Road, Suite 11, Holliston, MA 01746.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Harvard Apparatus Regenerative Technology, Inc. (HRGN).